Showing posts with label Amgen. Show all posts
Showing posts with label Amgen. Show all posts
Wednesday, July 4, 2018
Update on Aimovig
A quick update on my 2 month free trial of Aimovig. Remember, this is the first of the new class of migraine preventives - the first drugs ever to have been developed specifically to prevent migraines. They came out of fairly recent research that determined that migraines are not caused by vasodilation as previously believed, but rather are tied to an increase in a specific peptide, or protein, in the brain, (calcitonin gene-related peptide or CGRP). These drugs inhibit the CGRP, thus preventing migraine.
Aimovig is a self-administered, once a month injection. If you are interested, I suggest applying for the 2 month free trial. Amgen will end the injections to your home for free. I have just finished my first month and will receive the second dose in 2 days. So far, I have not seen a reduction in the number of migraine days, but the headaches I have are definitely milder. It is supposed to take as much as three months to experience the full effect of the medication, so I am still hopeful. But I am happy even now as I don't dread the headaches as I used to, and I have zero side effects. I definitely recommend it to all migraine sufferers.
Wednesday, June 6, 2018
P.S. to my migraine post
Today I received my first dose of Aimovig. It is the first of a new class of migraine preventives that is being developed. This is huge news for migraine sufferers. If you haven't heard of it, these CGRP* inhibitors are the first drugs ever developed specifically for migraine prevention. All other preventives that are used were developed to treat something else and then found to help prevent migraines in some people. They all have side effects and none of them has worked for me.
Aimovig is the first CGRP inhibitor to be approved by the FDA. Others are coming later this year. The great thing about these medications is that side effects are few and mild and they are proven to be effective in reducing migraine days by as much as half. They come in self-injectible pens and Aimovig has a 2 month free trial available. I just received and took my first dose. Super exciting. I'll let you know how it goes!
*Calcitonin Gene-related Peptide
Aimovig is the first CGRP inhibitor to be approved by the FDA. Others are coming later this year. The great thing about these medications is that side effects are few and mild and they are proven to be effective in reducing migraine days by as much as half. They come in self-injectible pens and Aimovig has a 2 month free trial available. I just received and took my first dose. Super exciting. I'll let you know how it goes!
*Calcitonin Gene-related Peptide
Subscribe to:
Posts (Atom)
-
© 2006 Alan Levine , Flickr | PD-CC0 | via Wylio As I mentioned in my previous post, my first breakthrough in figuring out what was wrong...
-
Hello all. As you can see, I have had to move my blog to a new location, but all the old posts are still here. I had to take the blog down f...
